Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Soc Nephrol ; 18(11): 2875-84, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17942968

RESUMO

Interferon-beta (IFN-beta) is a multifunctional cytokine with immunomodulatory properties. We examined the effect of IFN-beta in three separate rat models of glomerular injury and in cultured human glomerular endothelial cells and podocytes. In nephrotoxic nephritis in WKY rats, recombinant rat IFN-beta started either at induction or after establishment of disease significantly reduced 24-h proteinuria by up to 73% and 51%, respectively, but did not affect serum creatinine. There was a slight reduction in numbers of glomerular macrophages, but no difference in glomerular or tubulointerstitial scarring. In Thy-1 nephritis in Lewis rats, IFN-beta started at induction of disease reduced proteinuria by up to 66% with no effect on numbers of glomerular macrophages, but a reduced number of proliferating cells. In puromycin nephropathy in Wistar rats, IFN-beta started at induction of disease reduced proteinuria by up to 93%, but had no effect on glomerular histology. In cultured cells, human IFN-beta-1a had a dramatic effect on barrier properties, increasing electrical resistance across monolayers of either glomerular endothelial cells or podocytes and decreasing trans-monolayer passage of albumin. In conclusion, these results show that IFN-beta reduces proteinuria in three different rat models of glomerular injury and that its anti-proteinuric action may result from direct effects on cells that comprise the glomerular filtration barrier. These data indicate that IFN-beta may have potential as a therapeutic agent in proteinuric renal disease.


Assuntos
Glomerulonefrite/complicações , Glomerulonefrite/patologia , Fatores Imunológicos/uso terapêutico , Interferon beta/uso terapêutico , Proteinúria/prevenção & controle , Animais , Técnicas de Cultura de Células , Modelos Animais de Doenças , Células Endoteliais/efeitos dos fármacos , Taxa de Filtração Glomerular/efeitos dos fármacos , Glomerulonefrite/tratamento farmacológico , Humanos , Fatores Imunológicos/farmacologia , Interferon beta-1a , Interferon beta/farmacologia , Glomérulos Renais/efeitos dos fármacos , Glomérulos Renais/metabolismo , Glomérulos Renais/patologia , Proteinúria/etiologia , Ratos , Ratos Endogâmicos Lew , Ratos Endogâmicos WKY
2.
Eur J Immunol ; 36(1): 95-106, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16323245

RESUMO

Influenza viruses are serious respiratory pathogens, responsible for half a million deaths each year. The viral surface haemagglutinin (HA) protein has been shown to be an important determinant of viral pathogenicity. HA is the virion attachment and fusion protein, and the major target for neutralizing antibodies; however, it is also involved in triggering innate responses that may have an important impact on the disease course. We have examined the role of the toll-like receptor (TLR) family in innate responses to influenza virus and influenza HA. TLR7 has recently been found to mediate recognition of influenza RNA. Here, we show for the first time that influenza HA of the H2 subtype induces innate responses in murine B lymphocytes via a MyD88-dependent pathway distinct from that involved in sensing viral RNA. We also show that inactivated influenza virus induces activation of human B cells. Our findings suggest that the molecule mediating these responses may be a novel member of the TLR family.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Linfócitos B/imunologia , Hemaglutininas Virais/imunologia , Vírus da Influenza A/imunologia , Ativação Linfocitária/imunologia , Animais , Western Blotting , Hemaglutininas Virais/genética , Humanos , Interferons/biossíntese , Interferons/imunologia , Leucócitos Mononucleares/imunologia , Camundongos , Fator 88 de Diferenciação Mieloide , Receptores Toll-Like/imunologia
3.
J Immunol ; 175(10): 6275-85, 2005 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-16272278

RESUMO

Human coinfection with the helminth parasite Schistosoma mansoni and hepatitis B and hepatitis C viruses is associated with increased hepatic viral burdens and severe liver pathology. In this study we developed a murine S. mansoni/lymphocytic choriomeningitis virus (LCMV) coinfection model that reproduces the enhanced viral replication and liver pathology observed in human coinfections, and used this model to explore the mechanisms involved. Viral coinfection during the Th2-dominated granulomatous phase of the schistosome infection resulted in induction of a strong LCMV-specific T cell response, with infiltration of high numbers of LCMV-specific IFN-gamma-producing CD8+ cells into the liver. This was associated with suppression of production of the Th2 cytokines dominant during S. mansoni infection and a rapid increase in morbidity, linked to hepatotoxicity. Interestingly, the liver of coinfected mice was extremely susceptible to viral replication. This correlated with a reduced intrahepatic type I IFN response following virus infection. Schistosome egg Ags were found to suppress the type I IFN response induced in murine bone marrow-derived dendritic cells by polyinosinic-polycytidylic acid. These results suggest that suppression of the antiviral type I IFN response by schistosome egg Ags in vivo predisposes the liver to enhanced viral replication with ensuing immunopathological consequences, findings that may be paralleled in human schistosome/hepatotropic virus coinfections.


Assuntos
Infecções por Arenaviridae/complicações , Infecções por Arenaviridae/imunologia , Hepatite Viral Animal/complicações , Hepatite Viral Animal/imunologia , Vírus da Coriomeningite Linfocítica , Esquistossomose mansoni/complicações , Esquistossomose mansoni/imunologia , Animais , Antígenos de Helmintos , Infecções por Arenaviridae/patologia , Infecções por Arenaviridae/virologia , Citocinas/biossíntese , Modelos Animais de Doenças , Hepatite Viral Animal/patologia , Hepatite Viral Animal/virologia , Humanos , Interferon Tipo I/biossíntese , Fígado/parasitologia , Fígado/patologia , Fígado/virologia , Vírus da Coriomeningite Linfocítica/patogenicidade , Vírus da Coriomeningite Linfocítica/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Contagem de Ovos de Parasitas , Schistosoma mansoni/imunologia , Schistosoma mansoni/isolamento & purificação , Esquistossomose mansoni/parasitologia , Células Th2/imunologia , Fatores de Tempo , Replicação Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...